Defining Safe and Effective Cefazolin Dosing Regimens for MSSA Infections in the CNS: Leveraging Sparse Real-World Data and PBPK Modeling

Key Points

• Cefazolin dosing regimens were optimized using sparse real-world data, enhancing treatment for MSSA infections.
• The model estimates effective dosing to achieve therapeutic levels against MSSA infections in the CNS.
• Pharmacokinetic modeling provided insights into safe and effective dosing based on real-world patient data.
• This approach could improve outcomes in treating CNS infections, although further validation is essential.